Andere Kunden interessierten sich auch für
![Public/Private Partnerships in Education]( "Public/Private Partnerships in Education")
Public/Private Partnerships in Education51,99 €![A Governance Approach to Urban Water Public-Private Partnerships]( "A Governance Approach to Urban Water Public-Private Partnerships")
A Governance Approach to Urban Water Public-Private Partnerships35,99 €![Intricacies of Privatization and the Quest for Public Private Partnerships in Zambia]( "Intricacies of Privatization and the Quest for Public Private Partnerships in Zambia")
Intricacies of Privatization and the Quest for Public Private Partnerships in Zambia17,95 €![African Policy Innovation and the Political Economy of Public-Private Policy Partnerships]( "African Policy Innovation and the Political Economy of Public-Private Policy Partnerships")
African Policy Innovation and the Political Economy of Public-Private Policy Partnerships229,99 €![Governance & Design in Infrastructure Public Private Partnerships]( "Governance & Design in Infrastructure Public Private Partnerships")
Governance & Design in Infrastructure Public Private Partnerships70,99 €![Public-Private Partnerships in Health]( "Public-Private Partnerships in Health")
Public-Private Partnerships in Health37,99 €![Public-Private Partnerships in Health]( "Public-Private Partnerships in Health")
Public-Private Partnerships in Health37,99 €
For more than a decade, South Africa has been challenged by an impasse in its endeavours to integrate its readily available pharmaceutical resources in the private and public sectors in order to optimise pharmaceutical service delivery to the benefit of the people. The author describes a qualitative research inquiry by making use of a qualitative analysis, and submits a narrative of the information dissemination. A construct is proposed for a possible generic public-private partnership (PPP) model for pharmacy. Pharmacists in South Africa embrace the idea of Primary Care Drug Therapy reflecting on the potential of increasing primary care service delivery through the medium of joint ventures with the public sector that could result in a significantly increased capacity by means of mobilisation of the pharmaceutical sector's clinical capabilities. A report containing results and recommendations is presented, while relevant legislation and numerous themes are accessible by means of detailed appendices providing valuable information that may stimulate entrepreneurial advances.